about
Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicinThe role of the immune system in non-small cell lung carcinoma and potential for therapeutic interventionEGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cellsFrondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasisInhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1Seeing beyond the bronchoscope to increase the diagnostic yield of bronchoscopic biopsy.Induction of cell death by pyropheophorbide-α methyl ester-mediated photodynamic therapy in lung cancer A549 cells.Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growthCharacterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.Apoptosis block as a barrier to effective therapy in non small cell lung cancerINSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerReproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancerDeregulation of serum microRNA expression is associated with cigarette smoking and lung cancer.Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.Identification of logic relationships between genes and subtypes of non-small cell lung cancer.Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing.Gefitinib in non-small-cell lung cancer-an old lesson new re-visitedSquamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cellsEpigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.EML4-ALK fusion gene in Korean non-small cell lung cancerInhibition of DNA Synthesis by a Platinum-Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung CancerIdentification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancerEnhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non-small-cell Lung CancerLung cancer: Biology and treatment options.Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeletonEstablishing the role of tyrosine kinase 2 in cancer.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategiesBevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report.The cell's nucleolus: an emerging target for chemotherapeutic intervention.Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells.Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549.Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.
P2860
Q21134737-FFB66720-B9E7-4AD0-9F2E-307FAD5B7151Q27024781-BF92037A-7818-479F-807D-78F6AB7607B5Q28478401-FB66BBA9-A2B0-40A6-841E-EE47742B2259Q28484906-B7520C3A-2014-4A93-95E8-CC6287D2C711Q28534136-B7CBAD1E-BDD5-41D3-B630-39CE3D1FFA46Q30535417-13E1EFD9-AD64-48F9-A955-A3B6B3A74C5CQ32182272-28E2245F-3239-40FF-A649-6E1B611B939AQ33758978-AE011C3E-8297-47AB-B7ED-D7CE5CFF0A58Q33770896-A7457255-70CB-412D-8200-5FC521CF2825Q33851540-698B3FD1-C562-49A4-A87F-9518ACCB0017Q34031203-73C6D8B4-2A5B-4F4A-82FC-57C71C32907BQ34044082-8F137634-3477-455F-B170-5F12D7248888Q34067225-D1BE22E0-B285-4292-8BA2-BFDFCA066F00Q34441708-DF3B0FB4-A2E3-4AF7-84A3-9779CE234FA1Q34572581-FB83D408-7CEE-4A28-9B6E-E03EAD38EDCAQ35070124-37E5B23E-D99C-4471-BFF1-46F9FE154EBEQ35152155-D9BF74FA-1C52-49D6-8D5F-ED65C3DB063FQ35156166-FC95A47A-E3A0-4602-9D5F-51D473E8A5E9Q35200450-5DEF2BFB-BD5C-4DAC-A332-09CB467392CBQ35220347-285FD263-3BB1-47CA-8566-D39200A53928Q35267029-D97694BC-20E8-49BC-8C37-2557088DE62DQ35422300-1911C777-507E-4A0B-AD60-94B441B04E6AQ35677049-814C88E2-D6D3-4F51-A043-52059A2BA6C3Q35730962-0F975654-7F09-4D45-8EDA-CC76B973998BQ35743145-FAA9EF07-0964-4D87-A445-585E03324C32Q35811159-578AFB4A-0556-4B8B-A5E0-31B7A1DC5A2BQ35845192-9D59B8AB-A18B-4956-97B9-888A7ABE56DFQ35972500-BDBBF00A-E072-4BA4-9248-968567AF4F82Q36085398-139F5484-5C23-4DCF-A6A2-162B3F186017Q36192506-F5F021D2-2ADA-44CF-9128-8574ADF9596EQ36328370-1FFE25D0-D770-4E08-99A0-DFF27BBD54EAQ36535886-C215CCB1-34CF-491E-AB7C-149AC22C0AF2Q36643671-E5ACE3BD-A81D-4FA6-896E-DD8A777D2835Q36817080-110578A6-15CF-49A3-A3CB-899BE6223A15Q36850900-6DE26D04-BCEB-4558-8726-71BFA71643E3Q37001902-AFDAB257-3BEB-4ED3-816C-7C2B93B31456Q37484539-4B731FD9-AD24-4AFE-B0C7-A31E0A7AF49CQ37660148-B624D452-8953-4211-B1EC-89B963D91604Q37728759-DDDB310A-8D3F-4FF0-808A-8FB069D71335Q37894095-3F885E0C-5F92-4E2F-8AC2-F963B92F79CE
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Targeted therapies for non-small cell lung cancer.
@ast
Targeted therapies for non-small cell lung cancer.
@en
type
label
Targeted therapies for non-small cell lung cancer.
@ast
Targeted therapies for non-small cell lung cancer.
@en
prefLabel
Targeted therapies for non-small cell lung cancer.
@ast
Targeted therapies for non-small cell lung cancer.
@en
P2093
P1433
P1476
Targeted therapies for non-small cell lung cancer.
@en
P2093
Martin Reck
Tamas Suto
Wolfram C M Dempke
P304
P356
10.1016/J.LUNGCAN.2009.10.012
P577
2009-11-14T00:00:00Z